Lots of learnings, discussions, networking and fun!
#IBD #GAM3
👉 link.europa.eu/vGdQrY
#IHITransformingHealth #HealthResearch #EUResearch #RegulatoryScience
👉 link.europa.eu/vGdQrY
#IHITransformingHealth #HealthResearch #EUResearch #RegulatoryScience
Va ser un plaer explicar-vos el que fem a #Teamit i com el que heu fet fins ara és rellevant per a la nostra feina :)
🙌🏻 Molta sort!
#Careers
Sarai, Elena & Irene represented Teamit, meeting lots of brilliant people from the PRBB community. So much curiosity, energy & great conversations — thank you to everyone who came by! #Teamit #PRBB #Collaboration #Innovation #Research
Va ser un plaer explicar-vos el que fem a #Teamit i com el que heu fet fins ara és rellevant per a la nostra feina :)
🙌🏻 Molta sort!
#Careers
Join the leading international conference on drug repurposing to explore the next chapter in patient-centred innovation from rare diseases and AI to policy and funding.
Early Bird tickets available now ➡️ https://remedi4all.org/iDR26
Join the leading international conference on drug repurposing to explore the next chapter in patient-centred innovation from rare diseases and AI to policy and funding.
Early Bird tickets available now ➡️ https://remedi4all.org/iDR26
14 ECRs joined a week of hands-on training in patient-centred drug repurposing, tackling real-world challenges in rare neurodevelopmental disorders.
🔗More about REMEDi4ALL: https://loom.ly/5eKcLZs
14 ECRs joined a week of hands-on training in patient-centred drug repurposing, tackling real-world challenges in rare neurodevelopmental disorders.
🔗More about REMEDi4ALL: https://loom.ly/5eKcLZs
We reconnected with partners, reviewed achievements, and looked ahead to the project’s final phase. Highlights: Teamit presenting on communication & dissemination, as well as strategy talks and upcoming milestones!
More here: https://loom.ly/5eKcLZs
#MeetTheTeam #5YearsOfTeamit #Teamwork
#MeetTheTeam #5YearsOfTeamit #Teamwork
2.5 days full of patient stories, AI, policy discussions, trial designs & networking to make #DrugRepurposing the new normal💊🌍
👏Big thanks to all teams & speakers!
📰Great recap by @oriolguell.bsky.social
EN: loom.ly/qzQoFDY
#RareDiseases #PatientCentredResearch
🌍 300+ joined us in Amsterdam for two days of panels, posters, and powerful discussions on smarter routes to repurposed medicines.
👥 Thanks to our speakers and attendees for your insights, energy & contributions.
📖Highlights: remedi4all.org/idr25-wraps-...
2.5 days full of patient stories, AI, policy discussions, trial designs & networking to make #DrugRepurposing the new normal💊🌍
👏Big thanks to all teams & speakers!
📰Great recap by @oriolguell.bsky.social
EN: loom.ly/qzQoFDY
#RareDiseases #PatientCentredResearch
Workshop 1️⃣: HTA—a key tool for patient access 🔧
Workshop 2️⃣: Navigating the regulatory path for repurposing 🗺️
Register here! ➡️ loom.ly/0sIBcrg
Workshop 1️⃣: HTA—a key tool for patient access 🔧
Workshop 2️⃣: Navigating the regulatory path for repurposing 🗺️
Register here! ➡️ loom.ly/0sIBcrg
#RareDiseases #EuropeanHealth
#RareDiseases #EuropeanHealth
#ForOurFuture #HumanlyPossible #VaccinesWork
#ForOurFuture #HumanlyPossible #VaccinesWork
Interested in what we discussed at the FIBROTARGET General Assembly meeting last week in Milan? Discover our key takeaways in our web article!
📰Read our full wrap-up➡️ loom.ly/VDN6Fx4
📹Watch our highlights video below⬇️
Interested in what we discussed at the FIBROTARGET General Assembly meeting last week in Milan? Discover our key takeaways in our web article!
📰Read our full wrap-up➡️ loom.ly/VDN6Fx4
📹Watch our highlights video below⬇️
Lots of learnings, discussions, networking and fun!
#IBD #GAM3
Lots of learnings, discussions, networking and fun!
#IBD #GAM3
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆
More soon—stay tuned! 🔍
We are excited to announce that #iDR25 will be held at Felix Meritis, an iconic Amsterdam venue!
What to expect:
🔹 Engaging panels & talks
🔹 Networking opportunities
🔹 Interactive sessions
Don’t miss out! Register➡️ loom.ly/xGqLsX4
We are excited to announce that #iDR25 will be held at Felix Meritis, an iconic Amsterdam venue!
What to expect:
🔹 Engaging panels & talks
🔹 Networking opportunities
🔹 Interactive sessions
Don’t miss out! Register➡️ loom.ly/xGqLsX4
🟠 https://www.sciencedirect.com/science/article/pii/S0160412025000649?via%3Dihub
#UrbanHealth #GreenSpaces
🟠 https://www.sciencedirect.com/science/article/pii/S0160412025000649?via%3Dihub
#UrbanHealth #GreenSpaces
Watch our video below to learn more, & visit 👉 remedi4all.org
www.youtube.com/watch?v=w69O...
Watch our video below to learn more, & visit 👉 remedi4all.org
www.youtube.com/watch?v=w69O...
diarieducacio.cat/com-fer-serv...
diarieducacio.cat/com-fer-serv...
@ihieurope.bsky.social #PPP #platformtrials #MDD #innovation
🙌 Shout-out to Stefan Gold & team at Charité for launching a platform trial to test depression treatments simultaneously🧠 Proud to be part of this @ihieurope.bsky.social -funded legacy! Learn more🔗 loom.ly/cSQYIsE
@ihieurope.bsky.social #PPP #platformtrials #MDD #innovation
Join Beacon for Rare Diseases, @eurordis.bsky.social & @ecrin.bsky.social for a 3-part series on clinical trials, starting Fri 21 Feb! 🔬
📅 Session 1: Intro to Clinical Trials + Q&A
🕚 11:00–12:30 CET
🎟️ Register now ➡️ loom.ly/I91LsfI
Join Beacon for Rare Diseases, @eurordis.bsky.social & @ecrin.bsky.social for a 3-part series on clinical trials, starting Fri 21 Feb! 🔬
📅 Session 1: Intro to Clinical Trials + Q&A
🕚 11:00–12:30 CET
🎟️ Register now ➡️ loom.ly/I91LsfI
go.bsky.app/KcxvQLp
go.bsky.app/KcxvQLp
Learn more about this chilling risk & what can be done: tinyurl.com/2mhdhhje
Learn more about this chilling risk & what can be done: tinyurl.com/2mhdhhje
Join EFCCA's webinar with leading experts from
FIBROTARGET & patient reps. Dive into challenges, treatments, and innovations in #fibrosis!👥
🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET | 💻 Online 🎟️ Free: loom.ly/6WdjxOY
Join EFCCA's webinar with leading experts from
FIBROTARGET & patient reps. Dive into challenges, treatments, and innovations in #fibrosis!👥
🗓️ 6 Feb 2025 | 🕠 17:30-18:30 CET | 💻 Online 🎟️ Free: loom.ly/6WdjxOY